A detailed history of Casdin Capital, LLC transactions in Absci Corp stock. As of the latest transaction made, Casdin Capital, LLC holds 973,260 shares of ABSI stock, worth $2.96 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
973,260
Previous 973,260 -0.0%
Holding current value
$2.96 Million
Previous $3 Million 24.02%
% of portfolio
0.29%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.28 - $2.41 $505,600 - $951,950
-395,000 Reduced 28.87%
973,260 $1.28 Million
Q2 2023

Aug 14, 2023

SELL
$1.17 - $2.03 $4.71 Million - $8.17 Million
-4,025,000 Reduced 74.63%
1,368,260 $2.08 Million
Q1 2023

May 15, 2023

SELL
$1.58 - $3.41 $3.11 Million - $6.72 Million
-1,970,000 Reduced 26.75%
5,393,260 $9.44 Million
Q4 2022

Feb 14, 2023

SELL
$2.0 - $3.58 $710,666 - $1.27 Million
-355,333 Reduced 4.6%
7,363,260 $15.5 Million
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $80 Million - $234 Million
7,718,593 New
7,718,593 $89.8 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $282M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.